GeneralConnection.com ➔ Dictionary
Dictionary Search

indolent

Synonyms

Adjective

1. faineant

2. lazy, otiose, slothful, work-shy, idle, inactive

Usage
How Is Indolent Systemic Mastocytosis (ISM) Treated? - Health: Trusted and Empathetic Health and Wellness Information
FDA Orphan Drug Status Awarded to EO2463 in Indolent Non-Hodgkin Lymphoma - Targeted Oncology
Indolent primary cutaneous B-cell lymphomas resemble persistent antigen reactions without signs of dedifferentiation - Nature
HARBOR Trial Aims to Further Elucidate Potential Role for Elenestinib in Indolent Systemic Mastocytosis - OncLive
Does 8 Gy Improve Outcomes Over 4 Gy in Indolent Lymphoma? - Medscape
Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas - The New England Journal of Medicine
ASH 2025 | Congress coverage: Indolent and mantle cell NHL - Lymphoma Hub
5-Year Follow-Up From AUGMENT Lenalidomide Plus Rituximab in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma - The ASCO Post
Long-Term PIONEER Data Reinforce Avapritinib's Role in Indolent Systemic Mastocytosis - Dermatology Times
1 Reframing “Benign” Disease: The Modern Clinical Impact of Indolent Systemic Mastocytosis - HCPLive
Phase 2 Trial Will Evaluate CD19 t-haNK Combo in Indolent Lymphomas - CancerNetwork
Avapritinib Data Show Durable Benefits Including QOL in Indolent Systemic Mastocytosis: Lauren Madigan, MD - The American Journal of Managed Care® (AJMC®)
Shift in secretory profile of a pNET: from indolent glucagonoma to aggressive insulinoma – a case report - Frontiers
New Phase 2 Study of Tri-Modal Immunotherapy for Indolent B-Cell Lymphoma Launches - Targeted Oncology
Dr Radia on the Continued Investigation of Elenestinib in Indolent Systemic Mastocytosis - OncLive
Axicabtagene Ciloleucel in Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-up of ZUMA-5 - The ASCO Post
KIT D816V Biology and Longitudinal Symptom Assessment in Indolent Systemic Mastocytosis - HCPLive
How Will Indolent Lymphoma/B-Cell NHL Care Be Improved in the Future? - CancerNetwork
Avapritinib Yields Sustained Symptom Reduction and Safety in Indolent SM - OncLive
How Promising Are Immunotherapy Combos in Indolent Lymphoma? - CancerNetwork
Dr Tashi on the Effect of Avapritinib on Long-Term Bone Health in Indolent Systemic Mastocytosis - OncLive
Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis - PR Newswire
7 Possible Complications of Indolent Systemic Mastocytosis (ISM) - Health: Trusted and Empathetic Health and Wellness Information
Case Report - Baishideng Publishing Group
Indolent natural killer-cell lymphoproliferative disorder of the gallbladder: a rare case report - Frontiers
Indolent Tumour of the Upper Lip: A Case of Lobulated Acinic Cell Carcinoma - Cureus
Enterome receives U.S. FDA Orphan Drug Designation for - GlobeNewswire
How Is Indolent Systemic Mastocytosis (ISM) Treated? - AOL.com
10 Things That Can Trigger Indolent Systemic Mastocytosis Symptoms - Health: Trusted and Empathetic Health and Wellness Information
Avapritinib Demonstrates Durable Improvements in Indolent Systemic Mastocytosis Symptoms, QoL - HCPLive
Avapritinib's Effect Durable in Indolent Systemic Mastocytosis - MedPage Today
Current Standards of Care to Treat Patients With Indolent Systemic Mastocytosis - HCPLive
Ominous-appearing serosal findings on PSMA imaging might belie indolent clinical course - Nature
Cutaneous Acral Presentation of Indolent Mantle Cell Lymphoma With Prominent Nail Involvement and Atypical Immunophenotype - Wiley Online Library
Enterome presents Phase 2 indolent non-Hodgkin lymphoma - GlobeNewswire
ImmunityBio Launches Phase 2 Chemotherapy-Free CAR-NK Cell Therapy Trial with ANKTIVA® (ResQ215B) in Indolent Lymphomas - Business Wire
Future Directions in Indolent Systemic Mastocytosis Treatment - MedPage Today
Blueprint Medicines, a Sanofi Company, Highlights Long-Term Clinical Benefit of AYVAKIT® (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual Meeting - PR Newswire
Pipeline Therapies for Indolent Systemic Mastocytosis: Growing Confidence in the Treatment Landscape of Indolent Systemic Mastocytosis - HCPLive
‘Indolent and not photogenic’: can I make my reluctant cat a social media star in seven days? - The Guardian
San Diego workshops to focus on indolent systemic mastocytosis - Times of San Diego
Indolent Lymphoma Market Experiences Significant Growth Amid Evolving Therapeutic Landscape | DelveInsight - Yahoo Finance
Dr Tashi on Differentiating Characteristics of Elenestinib in Indolent Systemic Mastocytosis - OncLive
Considerations for Renaming Indolent Prostate Cancer in Different Practice Settings - Matthew Cooperberg & Nicolás Villareal Trujillo - UroToday
Avapritinib Benefit Persists at 3 Years for Indolent Systemic Mastocytosis - Oncology News Central
Understanding Indolent Systemic Mastocytosis (ISM): Symptoms and Impact - HCPLive
ALX Oncology Announces Positive Results from Ongoing - GlobeNewswire
Indolent Games confirms it is definitely not releasing CliveWareGOLD on 29th February 2026 - Games Press
18th International Conference on Malignant Lymphoma (ICML) congress coverage | Indolent and mantle cell NHL - Lymphoma Hub
Indolent Abdominal Wall Round Cell Sarcoma With EWSR1-PATZ1 Fusion: A Case Report and Literature Review - Cureus
In this issue: exploring the boundaries between neoplastic and reactive lymphoproliferations - Springer Nature Link
"Lethargic, Tardy and Indolent," Supreme Court Pulls Up Odisha Govt For 4 Months Delay in Filing SLP - LawBeat
Avapritinib versus Placebo in Indolent Systemic Mastocytosis - NEJM Evidence
Indolent lymphoma: addressing the needs of survivors - National Institutes of Health (.gov)
Many Patients with ISM Have Lower Survival - Cleveland Clinic
Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract - Haematologica
Indolent nodal T follicular helper cell lymphomas—A case series - Blood Cancer Journal - Nature
FDA Approves Avapritinib for Indolent Systemic Mastocytosis - OncLive
Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis - Haematologica
FDA Approves Avapritinib in Indolent Systemic Mastocytosis - CancerNetwork
Avapritinib Leads a Charge of Novel Targeted Therapies for Indolent Systemic Mastocytosis - OncLive
A new treatment without chemotherapy for indolent clinical forms of mantle cell lymphoma - Hospital Clínic Barcelona
Indolent but Capable! BellFine's Sakuna from Sakuna: Of Rice and Ruin - 玩具人 TOY PEOPLE
Defining Indolent Relapse Multiple Myeloma - Pharmacy Times
Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model - Nature
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma - The New England Journal of Medicine
Axi-Cel Efficacy in R/R Indolent Non-Hodgkin Lymphoma Sustained at 5 Years - Targeted Oncology
Response-Adapted Radiation Therapy for Orbital Indolent B-Cell Lymphoma - The ASCO Post
Beyond Serum Tryptase: Exploring Additional Testing Approaches for Indolent Systemic Mastocytosis - OncLive
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy - The New England Journal of Medicine
The Remaining Role for Radioimmunotherapy in Indolent Lymphoma - ASCO Daily News
Indolent Systemic Mastocytosis Treatment Market Size Analysis - Market.us Media
Bispecific antibodies in indolent B-cell lymphomas - Frontiers
Breyanzi Improves Responses in R/R Indolent B-Cell Non-Hodgkin Lymphoma - Cure Today
Soludo pays unscheduled visit to Anambra secretariat, warns indolent workers - Business News Nigeria
Identification of superficial invasive and indolent lymphomatous lymph nodes by multiple ultrasonographic vascular imaging - Nature
The Indolent Nature of Chronic Lymphocytic Leukemia - Cure Today
Indolent Metastatic ccRCC Disease Progression and Guideline Updates - Targeted Oncology
Advances in Lymphoma Research - National Cancer Institute (.gov)
Rituximab/Lenalidomide Shows Sustained PFS Benefit in Indolent Non-Hodgkin Lymphoma - OncLive
Low-Risk or Ultralow-Risk Breast Cancer? The Differences Are More Than Semantics - ASCO Daily News
Study Enrolling Women With Indolent MBC to Determine Benefit of Exercise: EMBody Trial - Cancer Nursing Today
Indolent Systemic Mastocytosis’ Diagnostic Clues, with Patricia Lugar, MD - HCPLive
Reproducing indolent B-cell lymphoma transformation with T-cell immunosuppression in LMP1/CD40-expressing mice - Nature
Genomic hallmarks of localized, non-indolent prostate cancer - Nature
Nearly One-Fifth of Screened Lung Cancer Cases May Be Indolent - CancerNetwork
MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics - Nature
Patient Case: A 61-Year-Old Patient with Indolent Metastatic ccRCC - Targeted Oncology
Indolent pocket wound in a cat - Vet Times
Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trial - The Lancet
Novel Combinations Seek to Build Off Lenalidomide/Rituximab Backbone in Indolent Lymphoma - OncLive
Reappraisal of autologous stem cell transplantation for transformed indolent lymphoma in the bendamustine era - Nature
Study Supports Bendamustine-Rituximab as Standard-of-Care in Patients With Indolent Non-Hodgkin Lymphoma - Pharmacy Times
Avapritinib Receives Support for Indolent Systemic Mastocytosis Indication in Europe - Docwire News
Ayvakit Approved for Indolent Systemic Mastocytosis - Medical Professionals Reference
Blueprint Medicines' AYVAKYT® (avapritinib) Receives European Commission Approval as the First and Only Treatment for Indolent Systemic Mastocytosis - PR Newswire
Differentiating Treatment Strategies for Indolent Versus Aggressive Relapse MM - Pharmacy Times
Very Low-Dose RT Is Effective, Although Not Standard in Indolent Non-Hodgkin Lymphoma - Oncology Nursing News
MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms - Nature
Recurrent Indolent Keratitis Caused by Achromobacter xylosoxidans: A Case Report and Literature Review - Cureus
Foreign Language Equivalents
Foreign Language Equivalents of 'indolent'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
inddolent,   indlent,   insolent,   indolnet,   indolwnt,   indoleny,   indolenr,   indilent,   indo;ent,   iindolent,   indolrnt,   indolebt,   infolent,   inodlent,   inolent,   indloent,   ibdolent,   indoelnt,   undolent,   nidolent,   imdolent,   indolnt,   indolen,   indokent,   indoent,   indolennt,   ondolent,   indolemt,   indoletn,   idnolent,   indoleent,   indollent,   indoolent,   inndolent,   ndolent,   indolet,   indolentt,   idolent,   indplent
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z